70-year-old woman diagnosed with SM despite atypical symptoms
A case report describes a woman diagnosed with and treated for systemic mastocytosis despite vague symptoms such as atypical skin lesions.
A case report describes a woman diagnosed with and treated for systemic mastocytosis despite vague symptoms such as atypical skin lesions.
A new study suggests that the phenotype of advanced systemic mastocytosis patients might provide clinicians with tools to offer diagnoses and prognoses.
Data from part 1 of a phase 2 trial showed bezuclastinib resulted in an overall improvement of quality of life for non-advanced SM patients.
In a recently published case study, a patient was diagnosed with SM via the Spanish Network on Mastocytosis (REMA) score.
Findings from the phase 2 PATHFINDER study presented at SOHO 2024 showed avapritinib had an overall positive effect in SM patients.
ARS Pharmaceuticals recently announced its nasal spray for type 1 allergic reactions has received FDA approval.
A recently published case study described a 4-year-old girl with both amyloid myeloid leukemia (AML) and systemic mastocytosis (SM).
A recent study found targeting eosinophils in nonadvanced SM may help those who have not found success with other treatments.
A recent study showed SM can be associated with severe complications and atypical symptoms, highlighting the need for a uniform diagnostic approach.
According to a recent study, chest CT scans are able to identify bronchial or lung lesions in patients with systemic mastocytosis (SM).